Which hedge funds own CMPX? COMPASS THERAPEUTICS INC, Q2 2026 13F holders
8 of the hedge funds tracked by WhaleCreep disclosed a position in CMPX (COMPASS THERAPEUTICS INC) in their Q2 2026 13F filings, worth $51.9m in total. The largest holder by portfolio weight is Suvretta Capital Management at 0.6% of its book. 2 managers opened a new position this quarter: Point72 Asset Management LP, Marshall Wace.
8tracked managers holding
2opened this quarter
0exited this quarter
Which hedge funds hold CMPX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Suvretta Capital Management | Q2 2026 | 0.6% | $30.9m | 14,101,159 | -1% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $10.3m | 4,713,247 | 457% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $7.8m | 3,570,674 | 395% | added |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $1.5m | 686,577 | – | new |
| Tudor Investment | Q2 2026 | 0.0% | $197.2k | 90,044 | 1% | added |
| Marshall Wace | Q2 2026 | 0.0% | $733.4k | 334,869 | – | new |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $22.3k | 10,202 | 0% | held |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $447.8k | 204,487 | 210% | added |
How has hedge fund ownership of CMPX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 8 | $51.9m |
| Q1 2026 | 6 | $84.9m |
| Q4 2025 | 1 | $76.2m |
| Q3 2025 | 2 | $49.6m |
| Q2 2025 | 2 | $19.2m |
| Q1 2025 | 1 | $610.9k |
| Q4 2024 | 1 | $404.0k |
| Q3 2024 | 1 | $409.6k |
| Q2 2024 | 1 | $140.6k |
| Q1 2024 | 1 | $139.0k |
| Q4 2023 | 2 | $2.8m |
| Q3 2023 | 2 | $3.2m |
| Q2 2023 | 1 | $5.2m |
| Q1 2023 | 3 | $6.1m |
| Q4 2022 | 2 | $10.3m |
| Q3 2022 | 2 | $4.7m |
Counts every tracked manager that disclosed CMPX in that quarter's filing, including managers that have since stopped filing.